Valerio Therapeutics Société anonyme (EPA:ALVIO)
0.1415
-0.0005 (-0.35%)
At close: Jan 30, 2026
EPA:ALVIO Market Cap
EPA:ALVIO has a market cap or net worth of €69.17 million as of January 30, 2026. Its market cap has increased by 475.22% in one year.
Market Cap
69.17M
Enterprise Value
90.03M
Revenue
1.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.14
Market Cap Chart
Since December 8, 2005, EPA:ALVIO's market cap has decreased from 72.77M to 69.17M, a decrease of -4.94%. That is a compound annual growth rate of -0.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 69.17M | 2.54% |
| Dec 31, 2025 | 67.46M | 484.18% |
| Dec 31, 2024 | 11.55M | -54.58% |
| Dec 29, 2023 | 25.42M | 62.58% |
| Dec 30, 2022 | 15.64M | -59.41% |
| Dec 31, 2021 | 38.52M | -25.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innate Pharma | 145.05M |
| ABIONYX Pharma | 134.06M |
| Adocia | 125.40M |
| MaaT Pharma | 117.57M |
| OSE Immunotherapeutics | 106.54M |
| Sensorion | 105.12M |
| Fermentalg | 41.13M |
| THX Pharma Société Anonyme | 34.49M |